{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:59:09Z","timestamp":1792447149306,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aimed to characterize abnormal liver function tests in patients with heart failure (HF), as they are commonly encountered yet poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We used data from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) to characterize associations with baseline liver function tests (LFTs). Each LFT was analysed as both a continuous and dichotomous variable [normal vs. abnormal; bilirubin &amp;gt;1.0\u2009mg\/dL; aspartate aminotransferase (AST) and alanine aminotransferase (ALT) &amp;gt;35\u2009mmol\/L]. Logistic regression assessed the association of LFTs and 30-day all-cause mortality and HF rehospitalization, and Cox proportional hazards assessed the association with 180-day all-cause mortality among patients alive at a 30-day landmark. In ASCEND-HF, 4228 (59%) had complete admission LFT data. Of these, 42% had abnormal bilirubin, 22% had abnormal ALT, and 30% had abnormal AST. Patients with abnormal LFTs were younger, had lower body mass index, and lower left ventricular ejection fraction. In multivariable models, increased total bilirubin was associated with increased 30-day mortality or HF rehospitalization [hazard ratio (HR) 1.17 per 1\u2009mg\/dL increase, 95% confidence interval (CI) 1.04, 1.32; P\u2009=\u20090.012], but not with an increase in 180-day mortality (HR 1.10, 95% CI 0.97, 1.25; P\u2009=\u20090.13) per 1\u2009mg\/dl increase. Compared with normal bilirubin levels, abnormal bilirubin was associated with increased 30-day mortality or HF rehospitalization (HR 1.24, 95% CI 1.00, 1.54; P\u2009=\u20090.048) and 180-day mortality (HR 1.32, 95% CI 1.08, 1.62; P\u2009=\u20090.007). We found no association with AST or ALT and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Greater than 40% of patients hospitalized with acute HF had abnormal LFTs. After multivariable adjustment, only elevated bilirubin was independently associated with worse clinical outcomes and may represent an important prognostic variable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.440","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T02:16:41Z","timestamp":1451269001000},"page":"424-432","source":"Crossref","is-referenced-by-count":67,"title":["Liver Function Tests in Patients with Acute Heart Failure and Associated Outcomes: Insights from ASCEND-HF"],"prefix":"10.1093","volume":"18","author":[{"given":"Marc D.","family":"Samsky","sequence":"first","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Dunning","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"DeVore","sequence":"additional","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip J.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Wilson Tang","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Canadian VIGOUR Centre"},{"name":"University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[{"name":"University of Alberta , Edmonton, Alberta ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Stony Brook University Hospital, Stony Brook , NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"McMurray","sequence":"additional","affiliation":[{"name":"Glasgow Cardiovascular Research Centre"},{"name":"University of Glasgow ,, Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Teerlink","sequence":"additional","affiliation":[{"name":"San Francisco VA Hospital, University of California, San Francisco and San Francisco VAMC, San Francisco , CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian A.","family":"Voors","sequence":"additional","affiliation":[{"name":"University of Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan B.","family":"Patel","sequence":"additional","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Duke University , Durham, NC ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"2026011721142653000_ejhf440-bib-0001","first-page":"e29","article-title":"Heart disease and stroke statistics\u20142015 update a report from the american heart association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"2026011721142653000_ejhf440-bib-0002","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2015.01.023","article-title":"Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure","volume":"115","author":"Ambrosy","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026011721142653000_ejhf440-bib-0003","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2013.03.042","article-title":"Cardiohepatic interactions in heart failure: an overview and clinical implications","volume":"61","author":"Samsky","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721142653000_ejhf440-bib-0004","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cardfail.2014.03.003","article-title":"Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study","volume":"20","author":"van Deursen","year":"2014","journal-title":"J Card Fail"},{"key":"2026011721142653000_ejhf440-bib-0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","article-title":"Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes","volume":"61","author":"Metra","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721142653000_ejhf440-bib-0006","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCHEARTFAILURE.108.826735","article-title":"Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure","volume":"2","author":"Poelzl","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2362.2011.02573.x","article-title":"Liver dysfunction in chronic heart failure: Prevalence, characteristics and prognostic significance","volume":"42","author":"Poelzl","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"2026011721142653000_ejhf440-bib-0008","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archinte.1987.00370070041006","article-title":"Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics","volume":"147","author":"Kubo","year":"1987","journal-title":"Arch Intern Med"},{"key":"2026011721142653000_ejhf440-bib-0009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721142653000_ejhf440-bib-0011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the everest trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"Van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"2026011721142653000_ejhf440-bib-0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011721142653000_ejhf440-bib-0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ahj.2008.07.031","article-title":"Rationale and design of the acute study of clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)","volume":"157","author":"Hernandez","year":"2009","journal-title":"Am Heart J"},{"key":"2026011721142653000_ejhf440-bib-0015","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMcpc049016","article-title":"Laboratory reference values","volume":"351","author":"Kratz","year":"2004","journal-title":"N Engl J Med"},{"key":"2026011721142653000_ejhf440-bib-0016","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/eurjhf\/hfs188","article-title":"Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: Findings from ASCEND-HF","volume":"15","author":"Mentz","year":"2013","journal-title":"Eur J Heart Fail."},{"key":"2026011721142653000_ejhf440-bib-0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCHEARTFAILURE.112.000204","article-title":"Relationship of right- to left-sided ventricular filling pressures in advanced heart failure insights from the escape trial","volume":"6","author":"Drazner","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMoa010641","article-title":"Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure","volume":"345","author":"Drazner","year":"2001","journal-title":"N Engl J Med"},{"key":"2026011721142653000_ejhf440-bib-0019","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-8703(84)90095-4","article-title":"Assessment of right ventricular function using two-dimensional echocardiography","volume":"107","author":"Kaul","year":"1984","journal-title":"Am Heart J"},{"key":"2026011721142653000_ejhf440-bib-0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026011721142653000_ejhf440-bib-0021","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/eurjhf\/hfq118","article-title":"Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality","volume":"12","author":"Damman","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0022","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/eurjhf\/hfq195","article-title":"Central venous pressure and impaired renal function in patients with acute heart failure","volume":"13","author":"Uthoff","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721142653000_ejhf440-bib-0023","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-009-1508-2","article-title":"Hypoxic hepatitis: Underlying conditions and risk factors for mortality in critically ill patients","volume":"35","author":"Fuhrmann","year":"2009","journal-title":"Intensive Care Med"},{"key":"2026011721142653000_ejhf440-bib-0024","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0168-8278(94)80226-2","article-title":"Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow","volume":"21","author":"Henrion","year":"1994","journal-title":"J Hepatol"},{"key":"2026011721142653000_ejhf440-bib-0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","article-title":"Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases","volume":"82","author":"Henrion","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2026011721142653000_ejhf440-bib-0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9343(00)00461-7","article-title":"Ischemic hepatitis: clinical presentation and pathogenesis","volume":"109","author":"Seeto","year":"2000","journal-title":"Am J Med."},{"key":"2026011721142653000_ejhf440-bib-0027","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00540-010-1058-3","article-title":"Hypoxic hepatitis in critically ill patients: Incidence, etiology and risk factors for mortality","volume":"25","author":"Raurich","year":"2011","journal-title":"J Anesth"},{"key":"2026011721142653000_ejhf440-bib-0028","first-page":"99","article-title":"The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry","volume":"2","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026011721142653000_ejhf440-bib-0029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9343(78)90819-7","article-title":"Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug","volume":"65","author":"Hepner","year":"1978","journal-title":"Am J Med"},{"key":"2026011721142653000_ejhf440-bib-0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/009127000004000102","article-title":"Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure","volume":"40","author":"Sokol","year":"2000","journal-title":"J Clin Pharm"},{"key":"2026011721142653000_ejhf440-bib-0031","first-page":"e28","article-title":"Heart disease and stroke statistics \u2013 2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"2026011721142653000_ejhf440-bib-0032","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM197402282900906","article-title":"Cardiac decompensation","volume":"290","author":"Ramirez","year":"1974","journal-title":"N Engl J Med"},{"key":"2026011721142653000_ejhf440-bib-0033","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026011721142653000_ejhf440-bib-0034","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2010.04.003","article-title":"Acute heart failure: Multiple clinical profiles and mechanisms require tailored therapy","volume":"144","author":"Metra","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026011721142653000_ejhf440-bib-0035","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","article-title":"Acute heart failure syndromes: Current state and framework for future research","volume":"112","author":"Gheorghiade","year":"2005","journal-title":"Circulation"},{"key":"2026011721142653000_ejhf440-bib-0036","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.440","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/4\/424\/66381224\/eurjhf_18_4_424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/4\/424\/66381224\/eurjhf_18_4_424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:14:50Z","timestamp":1768702490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/4\/424\/8423379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12,28]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.440","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,4]]},"published":{"date-parts":[[2015,12,28]]}}}